TEM
Tempus AI, Inc.
NASDAQ · USHealthcareMedical - Healthcare Information Services
$48.41-7.74%
Price as of Jul 20, 2026
TEM financials
Tempus AI, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $1.3B | $693.4M | $531.8M | $320.7M |
| Cost of revenue | $386.1M | $312.3M | $245.6M | $190.5M |
| Gross profit | $885.7M | $381.1M | $286.2M | $130.2M |
| Operating expenses | $1.1B | $1.1B | $482.3M | $395.6M |
| Operating income | -$238.6M | -$691.1M | -$196.1M | -$265.4M |
| Net income | -$245.0M | -$705.8M | -$214.1M | -$289.8M |
| EBITDA | -$222.4M | -$610.4M | -$133.3M | -$236.8M |
| Basic EPS | $-1.41 | $-4.60 | $-1.73 | $-1.97 |
| Diluted EPS | $-1.41 | $-4.60 | $-1.73 | $-1.97 |
| Balance sheet | ||||
| Cash & equivalents | $604.8M | $341.0M | $165.8M | $302.9M |
| Total assets | $2.3B | $926.1M | $564.1M | $631.4M |
| Total liabilities | $1.8B | $869.8M | $1.9B | $1.8B |
| Stockholders’ equity | $491.3M | $56.3M | -$1.4B | -$1.1B |
| Total debt | $1.3B | $468.1M | $488.1M | $433.0M |
| Net debt | $722.3M | $127.1M | $322.4M | $130.1M |
| Cash flow | ||||
| Operating cash flow | -$218.1M | -$189.0M | -$214.3M | -$168.2M |
| Capital expenditure | -$21.0M | -$22.1M | -$34.6M | -$18.4M |
| Free cash flow | -$239.1M | -$211.2M | -$248.9M | -$186.6M |
| Dividends paid | $0.00 | -$5.6M | -$5.6M | -$5.6M |
| Share repurchases | -$3.0M | $0.00 | -$3.6M | $0.00 |